Skip to main content

Table 3 Prediction of outcomes with SUVmax, TMTV and TLG

From: Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL)

  Progression-free survival Overall survival
SUVmax TMTV TLG SUVmax TMTV TLG
Se (%) 83.0 72.3 74.5 83.0 73.9 76.1
Sp (%) 37.8 81.1 62.2 39.5 81.6 63.2
Acc (%) 63.1 76.2 69.0 64.3 77.4 70.2
PPV (%) 62.9 82.9 71.4 62.9 82.9 71.4
NPV (%) 63.6 69.8 65.7 65.2 72.1 68.6
  1. Se sensitivity, Sp specificity, Acc accuracy, PPV positive predictive value, NPV negative predictive value, SUVmax maximum standardized uptake value, TMTV total metabolic tumor volume, TLG total lesion glycolysis